Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapyNPJ VACCINESIF6.52022-06-238OAAI
A β-catenin-TCF-sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal CancerFASEB JOURNALIF4.22022-05-130OA
A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal CancerCELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGYIF7.42022-01-019OAAI
An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancerEXPERT REVIEW OF CLINICAL PHARMACOLOGYIF32020-10-0610OAAI
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunityJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-08-2020OAAI
Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosityCANCER BIOLOGY & THERAPYIF4.62020-06-2811OAAI
APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axisCANCER BIOLOGY & THERAPYIF4.62020-02-0910OAAI
δ-Tocopherol Effect on Endocytosis and Its Combination with Enzyme Replacement Therapy for Lysosomal Disorders: A New Type of Drug Interaction?JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82019-09-015OAAI
The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and NeoplasiaFRONTIERS IN ONCOLOGYIF3.32018-08-0646OAAI
GUCY2C Signaling Opposes the Acute Radiation-Induced GI SyndromeCANCER RESEARCHIF16.62017-09-1417OAAI
Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancerEXPERT REVIEW OF CLINICAL PHARMACOLOGYIF32017-04-1028OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向